Yu Kyung Bae

Yu Kyung Bae

Auto-generated profile, based on publicly available information

Yu Kyung Bae

Department of Anesthesiology and Pain Medicine, Seoul National University Bundang Hospital, Seongnam, Korea

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2017 in Korean Journal of Anesthesiology
Verified
Journal Article
Open access
PDF file
CYChunwoo Yang
Chunwoo Yang
SJSung Mee Jung
Sung Mee Jung
YBYu Kyung Bae
Yu Kyung Bae
SPSang-Jin Park
Sang-Jin Park
Yang C, et al. Korean J Anesthesiol. 2017 Feb;70(1):64-71. https://doi.org/10.4097/kjae.2017.70.1.64

1 April 2025 in Korean Journal of Anesthesiology
Verified
Journal Article
Open access
PDF file
CKChang-Hoon Koo
Chang-Hoon Koo
SLSi Un Lee
Si Un Lee
HKHyeong-Geun Kim
Hyeong-Geun Kim
SLSoowon Lee
Soowon Lee
YBYu Kyung Bae
Yu Kyung Bae
JRJung-Hee Ryu
Jung-Hee Ryu
Background: Maintenance of stable blood pressure (BP) during cerebrovascular bypass surgery is crucial to prevent cerebral ischemia. We compared the effect of remimazolam anesthesia with that of propofol-induced and desflurane-maintained anesthesia on intraoperative hemodynamic stability and the need for vasoactive agents in patients undergoing cerebrovascular bypass surgery.Methods: Sixty-five patients were randomized into remimazolam (n = 31, remimazolam-based intravenous anesthesia) and control groups (n = 34, propofol-induced and desflurane-maintained anesthesia). The primary outcome was the occurrence of intraoperative hypotension. The secondary outcomes included hypotension duration, lowest mean BP (MBP), generalized average real variability (ARV) of MBP, and consumption of phenylephrine, norepinephrine, or remifentanil. Results: Occurrence rate and duration of hypotension were significantly lower in the remimazolam group (38.7% vs. 73.5%, P = 0.005; 0 [0, 10] vs. 7.5 [1.25, 25] min, P = 0.008). Remimazolam also showed better outcomes for lowest MBP (78 [73, 84] vs. 69.5 [66.25, 75.8] mmHg, P < 0.001) and generalized ARV of MBP (1.42 ± 0.49 vs. 1.66 ± 0.52 mmHg/min, P = 0.036). The remimazolam group required less phenylephrine (20 [0, 65] vs. 100 [60, 130] μg, P < 0.001), less norepinephrine (162 [0, 365.5] vs. 1335 [998.5, 1637.5] μg, P < 0.001), and more remifentanil (1750 [1454.5, 2184.5] vs. 531 [431, 746.5] μg, P < 0.001) than the control group.Conclusions: Remimazolam anesthesia may provide better hemodynamic stability during cerebrovascular bypass surgery than propofol-induced and desflurane-maintained anesthesia.

1 February 2026 in Korean Journal of Anesthesiology
Verified
Journal Article
Open access
PDF file
SLSoowon Lee
Soowon Lee
JRJung-Hee Ryu
Jung-Hee Ryu
CKChang-Hoon Koo
Chang-Hoon Koo
YBYu Kyung Bae
Yu Kyung Bae
AOAh-Young Oh
Ah-Young Oh
Background: Deep neuromuscular blockade (NMB) optimizes surgical conditions, particularly during laparoscopic procedures. However, its effects on systemic cytokines associated with anesthesia-related complications, including postoperative delirium and cognitive dysfunction, remain unclear. In this review, we quantified the impact of deep NMB on serum cytokine levels.Methods: PubMed, EMBASE, CENTRAL, CINAHL, Scopus, Web of Science, and Google Scholar databases were searched to identify randomized controlled trials (RCTs) evaluating serum cytokine levels in surgical patients under deep or moderate NMB.Results: Eight RCTs, including 661 patients undergoing laparoscopic and orthopedic surgeries, met the inclusion criteria. Immediately postoperatively, meta-analysis suggested a potential reduction in tumor necrosis factor-α (TNF-α, standardized mean difference: −0.46, 95% CI [−0.87 to −0.06], P = 0.03), with no significant differences in interleukin-1β (IL-1β) or interleukin-6 (IL-6) levels. At 24-h and 48-h postoperatively, no significant differences were observed in IL-1β, IL-6, TNF-α, or C-reactive protein levels. Meta-regression analysis indicated that inhalational anesthesia was associated with high IL-1β (estimate = 1.2135, 95% CI [0.5107–1.9162], P < 0.01) and TNF-α levels (estimate = 0.6271, 95% CI [0.0544–1.1997], P = 0.032) immediately postoperatively; however, younger patients exhibited elevated IL-1β levels under moderate NMB at 24-h postoperatively (estimate = 0.0242, 95% CI [0.0065–0.0419], P < 0.01).Conclusions: Deep NMB may be associated with reduced TNF-α levels immediately postoperatively. Inhalational anesthesia and younger age may contribute more to higher serum cytokine levels compared with total intravenous anesthesia and older age, respectively, suggesting a potential immunomodulatory effect of deep NMB. Further studies should clarify its clinical relevance.

18 April 2022 in Journal of Korean Neurosurgical Society
Verified
Journal Article
Open access
PDF file
CKChang-Hoon Koo
Chang-Hoon Koo
SJSo Young Ji
So Young Ji
YBYu Kyung Bae
Yu Kyung Bae
YJYoung-Tae Jeon
Young-Tae Jeon
JRJung-Hee Ryu
Jung-Hee Ryu
JHJung Ho Han
Jung Ho Han
Objective : This prospective, randomized, double-blinded trial aimed to evaluate the efficacy and safety of prophylactic ramosetron administration against postoperative nausea and vomiting (PONV) in patients undergoing microvascular decompression (MVD).Methods : In this study, 100 patients undergoing MVD were randomly allocated to the control (normal saline, 2 mL) or ramosetron (ramosetron, 0.3 mg) groups at the end of surgery. The incidence and severity of PONV, need for rescue antiemetics, patient satisfaction score, duration of hospital stay, and the occurrence of adverse events were evaluated 48 hours post-surgery.Results : Data obtained from 97 patients were included in the final analysis. The incidence of PONV was significantly lower in the ramosetron group than in the control group throughout the 48-hour postoperative period (29.2% vs. 51.0%, p=0.028). A similar trend was observed with regard to PONV severity (p=0.041). The need for rescue antiemetics, satisfaction score, duration of hospital stays, and the occurrence of adverse events did not significantly differ between the groups.Conclusion : Prophylactic ramosetron administration reduced the incidence and severity of PONV in patients undergoing MVD without causing serious adverse events. Thus, ramosetron use may improve patient recovery following MVD.

16 October 2024 in Anaesthesia Critical Care & Pain Medicine
Verified
Journal Article
Closed access
CKChang-Hoon Koo
Chang-Hoon Koo
SLSoowon Lee
Soowon Lee
SYSubin Yim
Subin Yim
YBYu Kyung Bae
Yu Kyung Bae
IPInsun Park
Insun Park
AOAh-Young Oh
Ah-Young Oh

25 June 2025 in The Korean Journal of Pain
Verified
Journal Article
Open access
PDF file
SLSoowon Lee
Soowon Lee
CKChang-Hoon Koo
Chang-Hoon Koo
YBYu Kyung Bae
Yu Kyung Bae
JRJung-Hee Ryu
Jung-Hee Ryu
Soowon Lee, Chang-Hoon Koo, Yu Kyung Bae, and Jung-Hee Ryu. Korean J Pain -0001;0:. https://doi.org/10.3344/kjp.25063